IVA.PA Gross Margin

The Gross Margin of Inventiva SA (IVA.PA) is 146.31%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

IVA.PA Gross Margin - Historical Value

Date	Value
2024-12-31	146.31%

IVA.PA Gross Margin - Peers Comparison

Ticker	Name	Value
BINV.ST	BioInvent International AB	42.37%
MAB.WA	Mabion SA	75.54%
XSPRAY.ST	XSpray Pharma AB (publ)	2539.90%
ABVX.PA	Abivax SA	-19700.00%
NANO.PA	Nanobiotix SA	100.00%
NANOV.OL	Nordic Nanovector ASA	7775.20%
SIGHT.PA	Gensight Biologics SA	188.37%
SLN.L	Silence Therapeutics PLC	3133.78%
TILS.L	Tiziana Life Sciences PLC	63.16%
DBV.PA	Dbv Technologies SA	83.62%
DMYD B.ST	Diamyd Medical AB	-10161.54%
HNSA.ST	Hansa Biopharma AB	51.23%
XBRANE.ST	Xbrane Biopharma AB	90.83%
ALBPS.PA	Biophytis SA	7775.20%
BVXP.L	Bioventix PLC	93.20%
IVACC.ST	Intervacc AB	-29.92%
ORPHA.CO	Orphazyme A/S	7775.20%
SNG.L	Synairgen PLC	68.75%
TNG.PA	Transgene SA	-700.96%
ALCLS.PA	Cellectis SA	6.96%
CANTA.ST	Cantargia AB	7775.20%
HPHA.DE	Heidelberg Pharma AG	74.01%
IPH.PA	Innate Pharma SA	94.50%
BGBIO.OL	Bergenbio ASA	100.00%
OSE.PA	OSE Immunotherapeutics SA	100.00%
POXEL.PA	Poxel SA	0.05%
SCLP.L	Scancell Holdings PLC	90.13%
VVY.AS	Vivoryon Therapeutics NV	85.42%
ALNOV.PA	Novacyt SA	32.21%
MOLN.SW	Molecular Partners AG	99.80%
ORY.MC	Oryzon Genomics SA	-4700.00%
VLA.PA	Valneva SE	41.89%